Targeting the Ubiquitylation and ISGylation Machinery for the Treatment of COVID-19. (2022)
Attributed to:
Substrate Peptidomimetic Inhibitors (SPIs) of the COP9 signalosome
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/biom12020300
PubMed Identifier: 35204803
Publication URI: http://europepmc.org/abstract/MED/35204803
Type: Journal Article/Review
Volume: 12
Parent Publication: Biomolecules
Issue: 2
ISSN: 2218-273X